CyanVac, Immuno Technologies announce long-lasting Lyme vaccine results
CyanVac LLC, a trailblazer in intranasal vaccine technology, in collaboration with Immuno Technologies, Inc., a leader in vaccines and diagnostics for Lyme disease, has unveiled ... Read More
Pfizer to invest $95m in French specialty vaccine company Valneva
US pharma giant Pfizer said that it will invest $95 million in Valneva, a French specialty vaccine company, for an 8.1% stake. The two firms ... Read More
Understanding Lyme Disease as the Great Imitator
For most adults and children, getting a tick bite is not a concerning experience. However, the increase in the number of cases of Lyme Disease ... Read More